Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Qiagen to EUR 47 from EUR 48.45 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on QGEN:
- QIAGEN announces partnership with Penn State University to advance microbiome sciences
- Qiagen partners with Penn State to advance microbiome sciences
- Qiagen announces details for completion of share repurchase up to $300M
- QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
- Qiagen rumor highlighted in Betaville blog
